Related Experiment Video

Updated: Jun 18, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy

Giuseppe Distefano1

  • 1Department of Pediatrics - Division of Neonatology and Pediatric Cardiology, University of Catania, Catania, Italy. distef@unict.it.

Italian Journal of Pediatrics
|November 26, 2009
PubMed

Insights

Anthracyclines are vital cancer drugs but can cause heart failure. Understanding their molecular effects on the heart may lead to new treatments for anthracycline-induced cardiomyopathy.

Area of Science:

  • Cardiology
  • Oncology
  • Molecular Biology

Background:

  • Anthracyclines are potent anticancer agents used in pediatric and adult oncology.
  • A significant limitation is their cardiotoxicity, leading to refractory chronic heart failure.
  • Anthracycline-induced cardiomyopathy (AIC) poses a serious clinical challenge.

Purpose of the Study:

  • To explore the subcellular molecular alterations underlying AIC.
  • To identify potential therapeutic strategies based on molecular pathogenetic mechanisms.

Main Methods:

  • Review of molecular mechanisms involved in anthracycline cardiotoxicity.
  • Analysis of subcellular changes including oxidative stress and apoptosis.
  • Examination of inflammatory signaling and gene expression alterations in cardiomyocytes.

Main Results:

  • Anthracyclines induce reactive oxygen species (ROS) formation.
  • Apoptosis and inflammatory signaling pathways are activated in cardiomyocytes.
  • Altered expression of cardiomyocyte-specific genes contributes to cardiotoxicity.

Conclusions:

  • Understanding AIC's molecular basis is crucial for managing cardiotoxicity.
  • Targeting specific molecular pathways offers new therapeutic perspectives for AIC.
  • Further research into AIC mechanisms can improve cancer patient outcomes.

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...